tamoxifen (Also tamoxifens) : Related Words Words similar in meaning to tamoxifen
- estrogen antagonist«
- tamoxifen«
- desmethyltamoxifen«
- breast cancer«
- nonsteroidal«
- estrogen«
- antagonist«
- idoxifene«
- risk«
- hydroxytamoxifen«
- drug«
- woman«
- endoxifen«
- effect«
- breast cancer recurrence«
- afimoxifene«
- active metabolite«
- serms«
- raloxifene«
- patient«
- medication«
- paroxetine«
- treatment«
- breast cancer patient«
- tissue«
- cancer«
- er+ patient«
- uterine cancer«
- tamoxifen treatment«
- er antagonist«
- premature puberty«
- affinity«
- estrogen action«
- cyp2d6 enzyme«
- osteoporosis«
- breast cell«
- walpole«
- albright syndrome«
- selective estrogen receptor modulators«
- erα«
- hormone«
- cyp2d6«
- sertraline«
- imperial college press«
- breast tissue«
- mccune«
- endometrial cancer«
- bone loss«
- gynecomastia«
- postmenopausal woman«
- riedel«
- fluoxetine«
- patent protection«
- er.«
- estradiol«
- ssri«
- compound«
- infertility«
- blood clot«
- clinical study«
- mania«
- recurrence«
- tissue selective action«
- testicular testosterone production«
- temporary chemical castration«
- tamoxifen/er complex«
- tamoxifen resistant cancer«
- tamoxifen prodrug«
- tamoxifen pioneering medicine«
- tamoxifen due«
- steatosis hepatis«
- steatorrhoeic hepatosis«
- star clinical study«
- smrt. tamoxifen function«
- short pubertal boy«
- serum igf«
- semantic memory score«
- reason tamoxifen«
- rapid bone maturation«
- protein pax2«
- proliferative erbb2 protein«
- premature growth plate«
- pre)cancerous cell«
- potent competitive aromatase inhibitor«
- potent antiestrogenic property«
- persistent retardation«
- other molecular biomarkers«
- norendoxifen«
- nonsteroidal agent«
- mature bone fusion«
- lox recombination technique«
- human contraception«
- harold w.c. ward«
- growth plate chondrocytes«
- funding v. craig jordan«
- erbb2/her2«
- er/tamoxifen complex recruit«
- er antagonist property«
- er antagonism«
- endogenous agonist estrogen«
- elevated estrogenic level«
- early breast cancer trialists«
- drug processing pathway«
- dna drug safety testing«
- didesmethyl-4-hydroxytamoxifen«
- desmethyl-4-hydroxytamoxifen«
- cytochrome p450 isoform cyp2d6«
- cyp2d6 status«
- cortical radial bone growth«
- contrast tamoxifen«
- compound alive«
- competitive metabolism«
- clinical trial picture«
- chemprevention«
- certain cyp2d6 variation«
- arthur l walpole«
- aromatase drug«
- anovulatory disorder«
- angiogenetic protocol«
- angiogenetic effect«
- alderley park research laboratory«
- aib-1 expression«
- advanced estrogen receptor«
- % fewer uterine cancer«
- % fewer blood clot«
- thyroiditis«
- potent cyp2d6 inhibitor«
- pioneering medicine«
- pax2 expression«
- nipple soreness«
- multifunctional medicine«
- limb lymphedema«
- late stage breast cancer«
- idiopathic sclerosing mesenteritis«
- gene cyp2d6«
- excessive estrogen«
- cyp2d6 phenotype«
- common hormone treatment«
- er«
- clinical trial«
- trioxifene«
- serm.«
- growth factor protein«
- dora richardson«
- cytocidal«
- antidepressant paroxetine«
- worse clinical outcome«
- serum lipid profile«
- selective estrogen«
- reduced cognition«
- nolvadex«
- ici pharmaceutical division«
- estrogen compound«
- er agonist«
- growth«
- tissue target«
- opposite breast«
- lymphedema treatment«
- hormonal drug«
- definitive response«
- breast cancer growth«
- study«
- er+«
- clomifene citrate«
- estrogen effect«
- dr. judah folkman«
- antiestrogenic activity«
- ncor«
- convincing effect«
- trial«
- v. craig jordan«
- receptor modulator«
- corporate priority«
- usd«
- ici pharmaceutical«
- collaborative group«
- breast«
- triglyceride concentration«
- clinical strategy«
- pax2«
- clomiphene citrate«
- ethamoxytriphetol«
- neuron activity«
- triphenylethylene«
- nuclear complex«
- health«
- tibolone«
- anticancer effect«
- skeletal growth«
- male breast cancer«
- luvox«
- lexapro«
- bipolar patient«
- dna variation«
- specific gene expression«
- reproductive endocrinologist«
- erbb2«
- bipolar disorder«
- responsive gene«
- additional indication«
- cardioprotective effect«
- worst outcome«
- retroperitoneal fibrosis«
- harvard researcher«
- celexa«
- bone«
- vitro assay«
- prevention«
- irregular period«
- folkman«
- future selection«
- invasive breast cancer«
- narcotic antagonist«
- antagonism«
- naltrexone«
- naloxone«
- antacid«
- nalorphine«
- 4-oht«
- 4-oht act«
- 4-hydroxy metabolite«
- 4-hydroxytamoxifen«
- Narcan«
- Nalline«